Anger Over Access To AstraZeneca's Evusheld Peaks In UK
Sales Of COVID-19 Antibody Have Slowed
News that the UK government will not procur any doses of AstraZeneca’s Evusheld for the prevention of COVID-19 infections in immunocompromised people has been greeted with dismay and the move will hurt the combo's already-limited sales growth.
